Literature DB >> 27909508

Arguments to Apply Epinephrine for Pocket Hematoma Reduction. The MAITRE Study.

Nikolay Ilov1, Nikolay Ilov1, Anatoly Nechepurenko1, Albert Abdulkadyrov1, Damir Paskeev1, Elena Damrina1, Elena Kulikova1, Marina Terent'eva1, Dinara Stompel1, Dmitry Tarasov1.   

Abstract

Pocket hematoma (PH) is a common complication of implantations of cardiac electrophysiological devices with occurring at a particularly high rate in patients on oral anticoagulation or antiplatelet treatment. Different pharmacological agents with hemostatic effect are used to avoid PH. We supposed that the vasoconstrictor effects of epinephrine may reduce bleeding extent and be effective in prevention of PH. Maitre is the first clinical trial conducted with an aim to show the safety and efficacy of epinephrine in PH prophylaxis. We randomized 133 patients to receive either epinephrine or saline solution, which were added to a local anesthetic administered during pacemaker implantation. In cases of diffuse bleeding a method of pocket drainage was effectively used. Results showed that risk of PH was significantly higher in the group receiving epinephrine. We conclude that a local epinephrine effect may lead to a false impression of adequate hemostasis and force a surgeon to refuse from drainage insertion.

Entities:  

Keywords:  Dual Antiplatelet; Electrophysiological; Epinephrine; Pocket Hematoma

Year:  2016        PMID: 27909508      PMCID: PMC5089502          DOI: 10.4022/jafib.1391

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  13 in total

1.  Prevention of pocket related complications with fibrin sealant in patients undergoing pacemaker implantation who are receiving anticoagulant treatment.

Authors:  Dragan J Milic; Zoran D Perisic; Sasa S Zivic; Zoran A Stanojkovic; Aleksandar M Stojkovic; Nevena D Karanovic; Nebojsa H Krstic; Sonja S Salinger
Journal:  Europace       Date:  2005-07       Impact factor: 5.214

2.  Cardiac device infections is associated with pocket hematoma and diabetes mellitus: the role of the cardiovascular nurse.

Authors:  Felisa V Martin-Casañas; Natalia Caballero-Estevez; Alberto Dominguez-Rodriguez; Pedro Abreu-Gonzalez; Ignacio Laynez-Cerdeña
Journal:  Int J Cardiol       Date:  2013-11-23       Impact factor: 4.164

Review 3.  Anticoagulation and antiplatelet therapy in implantation of electrophysiological devices.

Authors:  Panagiotis Korantzopoulos; Konstantinos P Letsas; Tong Liu; Nikolaos Fragakis; Michael Efremidis; John A Goudevenos
Journal:  Europace       Date:  2011-07-25       Impact factor: 5.214

4.  Pacemaker or defibrillator surgery without interruption of anticoagulation.

Authors:  David H Birnie; Jeff S Healey; George A Wells; Atul Verma; Anthony S Tang; Andrew D Krahn; Christopher S Simpson; Felix Ayala-Paredes; Benoit Coutu; Tiago L L Leiria; Vidal Essebag
Journal:  N Engl J Med       Date:  2013-05-09       Impact factor: 91.245

5.  Pocket related complications in 163 patients receiving anticoagulation or dual antiplatelet therapy: D-Stat Hemostat versus standard of care.

Authors:  Marc-Alexander Ohlow; Bernward Lauer; Bjoern Buchter; Matthias Schreiber; J Christoph Geller
Journal:  Int J Cardiol       Date:  2011-03-04       Impact factor: 4.164

6.  Association between hospital procedure volume and early complications after pacemaker implantation: results from a large, unselected, contemporary cohort of the German nationwide obligatory external quality assurance programme.

Authors:  Bernd Nowak; Karl Tasche; Linda Barnewold; Günther Heller; Boris Schmidt; Stefano Bordignon; K R Julian Chun; Alexander Fürnkranz; Rajendra H Mehta
Journal:  Europace       Date:  2015-03-01       Impact factor: 5.214

7.  Risk of hematoma complications after device implant in the clopidogrel era.

Authors:  Ilana B Kutinsky; Regina Jarandilla; Maralee Jewett; David E Haines
Journal:  Circ Arrhythm Electrophysiol       Date:  2010-06-17

8.  Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy.

Authors:  Uwe K H Wiegand; Dominik LeJeune; Frank Boguschewski; Hendrik Bonnemeier; Frank Eberhardt; Heribert Schunkert; Frank Bode
Journal:  Chest       Date:  2004-10       Impact factor: 9.410

9.  Hematoma complicating permanent pacemaker implantation: the role of periprocedural antiplatelet or anticoagulant therapy.

Authors:  Kazım Serhan Özcan; Damirbek Osmonov; Ersin Yıldırım; Servet Altay; Ceyhan Türkkan; Ahmet Ekmekçi; Barış Güngör; Izzet Erdinler
Journal:  J Cardiol       Date:  2013-04-21       Impact factor: 3.159

10.  Thrombocytopenia, dual antiplatelet therapy, and heparin bridging strategy increase pocket hematoma complications in patients undergoing cardiac rhythm device implantation.

Authors:  Huang-Chung Chen; Yung-Lung Chen; Bih-Fang Guo; Tzu-Hsien Tsai; Jen-Ping Chang; Kuo-Li Pan; Yu-Sheng Lin; Mien-Cheng Chen
Journal:  Can J Cardiol       Date:  2013-03-06       Impact factor: 5.223

View more
  1 in total

1.  CIED implantation in elderly patients: a single-center experience.

Authors:  Nikolay N Ilov; Anatoly A Nechepurenko; Albert M Abdulkadyrov; Damir R Paskeev; Timur F Asfandiyarov; Dmitry G Tarasov
Journal:  J Geriatr Cardiol       Date:  2018-06       Impact factor: 3.327

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.